SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009680
Filing Date
2023-05-15
Accepted
2023-05-15 07:00:45
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20230331x10q.htm   iXBRL 10-Q 1793236
2 EX-10.1 elev-20230331xex10d1.htm EX-10.1 44234
3 EX-31 elev-20230331xex31.htm EX-31 15648
4 EX-32 elev-20230331xex32.htm EX-32 6554
  Complete submission text file 0001558370-23-009680.txt   6941553

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20230331.xsd EX-101.SCH 44994
6 EX-101.CAL elev-20230331_cal.xml EX-101.CAL 37651
7 EX-101.DEF elev-20230331_def.xml EX-101.DEF 185397
8 EX-101.LAB elev-20230331_lab.xml EX-101.LAB 430051
9 EX-101.PRE elev-20230331_pre.xml EX-101.PRE 333423
64 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230331x10q_htm.xml XML 1116693
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 23918327
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences